Reducing this specific fat depot improves health markers beyond what overall weight loss alone achieves
Okumura Y, Sugiyama T
Zepbound covers weight management and sleep apnea, while the same molecule as Mounjaro is approved for type 2 diabetes
Clinical research involving intravenous DSIP administration in humans has shown increased sleep duration, improved sleep efficiency, and reduced sleep interruptions compared with placebo
Always consult a qualified healthcare provider before starting or modifying any hormone therapy, peptide protocol, or medical treatment
Update: An October 2024 Clinical Practice Guidance joint statement by multiple medical societies (American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) states that most patients should continue taking their GLP-1 drugs before elective surgery